- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 2170694-05-8] IRAK4-IN-22
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-151365 |
| Brand: | MCE |
| CAS: | 2170694-05-8 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | 513.57 |
| Molecular Formula | C28H28FN7O2 |
| SMILES | O=C([C@H]1[C@@H](C2)C=C[C@@H]2[C@H]1NC3=NC(NC4=CC=CC(C(N5CCCC5)=O)=C4)=NC=C3C6=CC(F)=NC=C6)N |
Summary
IRAK4-IN-22 (compound 18) is an orally active, potent and selective IRAK4 inhibitor with IC 50 values of 3 and 17 nM for IRAK4 and TAK1 , respectively. IRAK4-IN-21 effectively inhibits IL-23 production ( IC 50 =0.10 µM) and can be used in studies of autoimmune diseases such as plaque psoriasis and psoriatic arthritis [1] .
In Vitro
IRAK4-IN-21 (a 4-fold serial dilution from 10 µM; 1 h) decreases the levels of IL-23 (in THP-1 and DC cells), IL-6 (in HUVEC cells) and MIP-1β (in human whole blood) [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
| Cell Line: | THP-1, DC cells (are primed with IFN-γ) |
| Concentration: | 10 µM (a 4-fold serial dilution from 10 µM) |
| Incubation Time: | 1 h (pre-incubate) |
| Result: | Inhibited the levels of IL-23 in the supernatant of THP-1 and DC cells with IC 50 of 0.10 and 0.11 µM, respectively. |
Cell Viability Assay [1]
| Cell Line: | HUVEC cells (IL-1β-stimulated) |
| Concentration: | 10 µM (a 4-fold serial dilution from 10 µM) |
| Incubation Time: | 1 h (pre-incubate) |
| Result: | Inhibited the level of IL-6 in the supernatant of HUVEC cells with an IC 50 of 0.11 µM. |
Cell Viability Assay [1]
| Cell Line: | Human whole blood (IL-1β-stimulated) |
| Concentration: | 10 µM (a 4-fold serial dilution from 10 µM) |
| Incubation Time: | 1 h (pre-incubate) |
| Result: | Inhibited the level of MIP-1β in the human whole blood with an IC 50 of 0.51 µM. |
In Vivo
IRAK4-IN-21 (75 mg/kg; p.o.; single) shows moderate efficacy in acute animal model studies for the inhibition of IL-6 production [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | BALB/c mice (acute mouse model; IL-1β-stimulated) [1] . |
| Dosage: | 75 mg/kg |
| Administration: | Oral administration; single (pre-treat). |
| Result: | Showed 64% inhibition of IL-6, plasma concentrations was 6817 ng/mL at 0.5 h and 700 ng/mL at 2 h. |
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.